Syncom Formulations (India) Limited (BOM:524470)
15.21
+0.29 (1.94%)
At close: Aug 17, 2026
BOM:524470 Market Cap
BOM:524470 has a market cap or net worth of 14.02 billion as of August 17, 2026. Its market cap has decreased by -13.51% in one year.
Market Cap
14.02B
Enterprise Value
12.91B
Revenue
4.89B
Ranking
n/a
PE Ratio
18.42
Stock Price
15.21
ChartMarket Cap Chart
Since December 31, 2001, BOM:524470's market cap has increased from 267.05M to 14.02B, an increase of 5,151.78%. That is a compound annual growth rate of 17.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 14.02B | 4.56% |
| Dec 31, 2025 | 13.41B | -28.65% |
| Dec 31, 2024 | 18.80B | 32.98% |
| Dec 29, 2023 | 14.14B | 69.37% |
| Dec 30, 2022 | 8.35B | -23.58% |
| Dec 31, 2021 | 10.92B | 305.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 23.88B |
| Shukra Pharmaceuticals | 18.21B |
| TTK Healthcare | 16.40B |
| Amrutanjan Health Care | 14.30B |
| Fermenta Biotech | 12.88B |
| Lincoln Pharmaceuticals | 12.28B |
| Bharat Parenterals | 9.30B |
| Kopran | 9.18B |